Genuity Science

company

About

Genomics Medicine Ireland is an Irish life sciences company.

  • 51 - 100

Details

Last Funding Type
Series C
Last Funding Money Raised
$200M
Industries
Analytics,Big Data,Bioinformatics,Biotechnology,Genetics,Health Care,Health Diagnostics
Founded date
Jan 1, 2013
Number Of Employee
51 - 100
Operating Status
Close

Genuity Science is a contract genomics and data-sourcing, –analytics and –insights organization headquartered in Boston, Massachusetts, USA with offices in Dublin, Ireland and Reykjavik, Iceland. Genuity partners with global biopharma companies to offer deep end-to-end discovery services aimed at catalyzing precision health and improving the quality of life for patients around the world. Services include population-scale, disease-specific data sourcing, high-quality sequencing, robust statistical analysis and software tools for analyzing large datasets and artificial intelligence (AI). The company operates advanced CAP/CLIA genomics laboratories in Woburn, Massachusetts, USA and in Dublin, Ireland and is deeply committed to data stewardship and data governance across its global offices. For more information, see www.genuitysci.com.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$380M
Genuity Science has raised a total of $380M in funding over 2 rounds. Their latest funding was raised on Nov 27, 2018 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 27, 2018 Series C $200M 1 Detail
Sep 5, 2017 Series B $165M 1 Sequoia Capital Detail
Oct 23, 2013 Series A $15M 1 Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Genuity Science has made 2 investments. Their most recent investment was on Feb 6, 2019, when DNAnexus raised $68M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 6, 2019 DNAnexus
Series F $68M Bioinformatics
Jan 2, 2018 DNAnexus
Series E $58M Bioinformatics

Investors

Number of Lead Investors
Number of Investors
1
2
Genuity Science is funded by 2 investors. Sequoia Capital and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Sequoia Capital Series C
ARCH Venture Partners Series A